WY-14,643-induced cell proliferation and oxidative stress in mouse liver are independent of NADPH oxidase

Toxicological Sciences

Volumn 98, Issue 2, 2007, Pages 366-374

  Woods, Courtney G ^a   Burns, Amanda M ^a   Bradford, Blair U ^a   Ross, Pamela K ^a   Kosyk, Oksana ^a   Swenberg, James A ^a   Cunningham, Michael L ^b   Rusyn, Ivan ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Carcinogenesis; Kupffer cells; Peroxisome proliferators; PPAR

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PIRINIXIC ACID; PROTEIN P47; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DIVISION; CELL PROLIFERATION; CHRONIC TOXICITY; CONTROLLED STUDY; DNA DAMAGE; ENZYME DEFICIENCY; GENETIC CODE; HISTOPATHOLOGY; KUPFFER CELL; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER PARENCHYMA; LIVER SIZE; LIVER TOXICITY; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; TOXICOKINETICS; WILD TYPE;

ACYL-COA OXIDASE; ANIMALS; APOPTOSIS; BODY WEIGHT; CASPASE 8; CASPASE 9; CELL CYCLE PROTEINS; CELL PROLIFERATION; DNA DAMAGE; LIVER; MALE; MICE; MICE, KNOCKOUT; NADPH OXIDASE; ORGAN SIZE; OXIDATIVE STRESS; PEROXISOME PROLIFERATORS; PPAR ALPHA; PYRIMIDINES;

MUS; RODENTIA;

EID: 34547830255     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfm104     Document Type: Article

References (51)

1. Anderson, S. P., Dunn, C. S., Cattley, R. C., and Corton, J. C. (2001). Hepatocellular proliferation in response to a peroxisome proliferator does not require TNFalpha signaling. Carcinogenesis 22(11), 1843-1851.
2. Bayly, A. C., Roberts, R. A., and Dive, C. (1994). Suppression of liver cell apoptosis in vitro by the non-genotoxic hepatocarcinogen and peroxisome proliferator nafenopin. J. Cell Biol. 125(1), 197-203.
3. Bojes, H. K., Germolec, D. R., Simeonova, P., Bruccoleri, A., Schoonhoven, R., Luster, M. I., and Thurman, R. G. (1997a). Antibodies to tumor necrosis factor alpha prevent increases in cell replication in liver due to the potent peroxisome proliferator, WY-14,643. Carcinogenesis 18(4), 669-674.
4. Bojes, H. K., Rose, M. L., Keller, B. J., Germolec, D. R., Simeonova, P., Luster, M. I., and Thurman, R. G. (1997b). Mitogenic actions of peroxidase proliferators: Involvement of protein kinase C and tumor necrosis factor alpha. Drug Metab. Rev. 29(1-2), 235-260.
5. Calfee-Mason, K. G., Spear, B. T., and Glauert, H. P. (2004). Effects of vitamin E on the NF-kappaB pathway in rats treated with the peroxisome proliferator, ciprolibrate. Toxicol. Appl. Pharmacol. 199 1), 1-9.
6. Conway, J. G., Tomaszewski, K. E., Olson, M. J., Cattley, R. C., Marsman, D. S., and Popp, J. A. (1989). Relationship of oxidative damage to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and Wy-14,643. Carcinogenesis 10 3), 513-519.
7. Deutsch, W. A., Kukreja, A., Shane, B., and Hegde, V. (2001). Phenobarbital, oxazeparn. and Wyeth 14,643 cause DNA damage as measured by the Comet assay. Mutagenesis 16(5), 439-442.
8. Glauert, H. P., Eyigor, A., Tharappel, J. C., Cooper, S., Lee, E. Y., and Spear, B. T. (2006). Inhibition of hepatocarcinogenesis by the deletion of the p50 subunit of NF-{kappa}B in mice administered the peroxisome proliferator Wy-14,643. Toxicol. Sci. 90(2), 331-336.
9. Guttridge, D. C., Albanese, C., Reuther, J. Y., Pestell, R. G., and Baldwin, A. S., Jr. (1999). NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol. Cell. Biol. 19(8), 5785-5799.
10. Hasmall, S. C., James, N. H., Hedley, K., Olsen, K., and Roberts, R. A. (2001). Mouse hepatocyte response to peroxisome proliferators: Dependency on hepatic nonparenchymal cells and peroxisome proliferator receptor α (PPARα). Arch. Toxicol. 75, 357-361.
11. Hasmall, S. C., James, N. H., Macdonald, N., Gonzalez, F. J., Peters, J. M., and Roberts, R. A. (2000). Suppression of mouse hepatocyte apoptosis by peroxisome proliferators: Role of PPARalpha and TNFalpha. Mutat. Res. 448(2), 193-200.
12. Hays, T., Rusyn, I., Burns, A. M., Kennett, M. J., Ward, J. M., Gonzalez, F. J., and Peters, J. M. (2005). Role of peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafibrate-induced hepatocarcinogenesis and cholestasis. Carcinogenesis 26(1), 219-227.
13. Hurtt, M. E., Elliott, G. S., Cook, J. C., Obourn, J. D., Frame, S. R., and Biegel, L. B. (1997). Induction of coagulation effects by Wyeth-14,643 in Crl:CD BR rats. Drug Chem. Toxicol. 20 (1-2), 1-10.
14. phox mouse knock-out model of chronic granulomatous disease. J. Exp. Med. 182(3), 751-758.
15. Johnson, T. E., Zhang, X., Shi, S., and Umbenhauer, D. R. (2005). Statins and PPARalpha agonists induce myotoxicity in differentiated rat skeletal muscle cultures but do not exhibit synergy with co-treatment. Toxicol. Appl. Pharmacol. 208(3), 210-221.
16. Lalwani, N. D., Reddy, M. K., Qureshi, S. A., and Reddy, J. K. (1981). Development of hepatocellular carcinomas and increased peroxisomal fatty acid beta-oxidation in rats fed [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (Wy-14,643) in the semipurified diet. Carcinogenesis 2(7), 645-650.
17. Lawrence, J. W., Wollenberg, G. K., and Deluca, J. G. (2001). Tumor necrosis factor alpha is not required for VVY14,643-induced cell proliferation. Carcinogenesis 22(3), 381-386.
18. Lee, S. S., Pineau, T., Drago, J., Lee, E. J., Owens, J. W., Kroetz, D. L., Fernandez-Salguero, P. M., Westphal, H., and Gonzalez, F. J. (1995). Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell. Biol. 15(6), 3012-3022.
19. Li, Y., Leung, L. K., Glauert, H. R, and Spear, B. T. (1996). Treatment of rats with the peroxisome proliferator ciprolibrate results in increased liver NF-kappaB activity. Carcinogenesis 17(11), 2305-2309.
20. Marsman, D. S., Cattley, R. C., Conway, J. G., and Popp, J. A. (1988). Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats. Cancer Res. 48(23), 6739-6744.
21. Mauton, P. R. (2002). Principles and Practices of Unbiased Stereology: An Introduction for Bioscientists. The Johns Hopkins University Press, Baltimore, MD.
22. Menegazzi, M., Carcereri-De Prati, A., Suzuki, H., Shinozuka, H., Pibiri, M., Piga, R., Columbano, A., and Ledda-Columbano, G. M. (1997). Liver cell proliferation induced by nafenopin and cyproterone acetate is not associated with increases in activation of transcription factors NF-kappaB and AP-1 or with expression of tumor necrosis factor alpha. Hepatology 25(3), 585-592.
23. Nakamura, J., La, D. K., and Swenberg, J. A. (2000). 5′-Nicked apurinic/apyrimidinic sites are resistant to β-elimination by β-polymerase and are persistent in human cultured cells after oxidative stress. J. Biol. Chem 275(8), 5323-5328.
24. Nakamura, J., and Swenberg, J. A. (1999). Endogenous apurinic/ apyrimidinic sites in genomic DNA of mammalian tissues. Cancer Res. 59(11), 2522-2526.
25. Nash, T. (1953). The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. Biochem. J. 55(3), 416-421.
26. Ohmura, T., Ledda-Columbano, G. M., Piga, R., Columbano, A., Glemba, J., Katyal, S. L., Locker, J., and Shinozuka, H. (1996). Hepatocyte proliferation induced by a single dose of a peroxisome proliferator. Am. J. Pathol. 148(3), 815-824.
27. Parzefall, W., Berger, W., Kainzbauer, E., Teufelhofer, O., Schulte-Hermann, R., and Thurman, R. G. (2001). Peroxisome proliferators do not increase DNA synthesis in purified rat hepatocytes. Carcinogenesis 22(3), 519-523.
28. Peters, J. M., Aoyama, T., Cattley, R. C., Noburnitsu, U., Hashimoto, T., and Gonzalez, F. J. (1998). Role of peroxisome proliferator-activated receptor alpha in altered cell cycle regulation in mouse liver. Carcinogenesis 19(11), 1989-1994.
29. Peters, J. M., Cattley, R. C., and Gonzalez, F. J. (1997). Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy- 14,643. Carcinogenesis 18(11), 2029-2033.
30. Peters, J. M., Rusyn, I., Rose, M. L., Gonzalez, F. J., and Thurman, R. G. (2000). Peroxisome proliferator-activated receptor alpha is restricted to hepatic parenchymal cells, not Kupffer cells: Implications for the mechanism of action of peroxisome proliferators in hepatocarcinogenesis. Carcinogenesis 21(4), 823-826.
31. Reddy, J. K., Moody, D. E., Azarnoff, D. L., and Rao, M. S. (1976). Di(2-ethylhexyl)phthalate: An industrial plasticizer induces hypolipidemia and enhances hepatic catalase and carnitine acetyltransferase activities in rat and mice. Life Sci. 18 9), 941-945.
32. Reddy, J. K., and Rao, M. S. (1989). Oxidative DNA damage caused by persistent peroxisome proliferation: Its role in hepatocarcinogenesis. Mutat. Res. 214(1), 63-68.
33. Reddy, J. K., Rao, M. S., Azarnoff, D. L., and Sell, S. (1979). Mitogenic and carcinogenic effects of a hypolipidemic peroxisome proliferator, [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643), in rat and mouse liver. Cancer Res. 39(1), 152-161.
34. Rolfe, M., James, N. H., and Roberts, R. A. (1997). Tumour necrosis factor alpha (TNF alpha) suppresses apoptosis and induces DNA synthesis in rodent hepatocytes: A mediator of the hepatocarcinogenicity of peroxisome proliferators? Carcinogenesis 18(11), 2277-2280.
35. Rose, M. L., Germolec, D., Arteel, G. E., Schoonhoven, R., and Thurman, R. G. (1997a). Dietary glycine prevents increases in hepatocyte proliferation caused by the peroxisome proliferator WY-14,643. Chem. Res. Toxicol. 10(10), 1198-1204.
36. Rose, M. L., Germolec, D. R., Schoonboven, R., and Thurman, R. G. (1997b). Kupffer cells are causally responsible for the mitogenic effect of peroxisome proliferators. Carcinogenesis 18(8), 1453-1456.
37. Rose, M. L., Rivera, C. A., Bradford, B. U., Graves, L. M., Cattley, R. C., Schoonhoven, R., Swenberg, J. A., and Thurman, R. G. (1999). Kupffer cell oxidant production is central to the mechanism of peroxisome proliferators. Carcinogenesis 20(1), 27-33.
38. Rose, M. L., Rusyn, I., Bojes, H. K., Belyea, J., Cattley, R. C., and Thurman, R. G. (2000). Role of Kupffer cells and oxidants in signaling peroxisome proliferator-induced hepatocyte proliferation. Mutat. Res. 448(2), 179-192.
39. Rusyn, I., Asakura, S., Pachkowski, B., Bradford, B. U., Denissenko, M. F., Peters, J. M., Holland, S. M., Reddy, J. K., Cunningham, M. L., and Swenberg, J. A. (2004). Expression of base excision DNA repair genes is a sensitive biomarker for in vivo detection of chemical-induced chronic oxidative stress: Identification of the molecular source of radicals responsible for DNA damage by peroxisome proliferators. Cancer Res. 64(3), 1050-1057.
40. Rusyn, I., Kadiiska, M. B., Dikalova, A., Kono, H., Yin, M., Tsuchiya, K., Mason, R. P., Peters, J. M., Gonzalez, F. J., Segal, B. H., et al. (2001). Phthalates rapidly increase production of reactive oxygen species in vivo: Role of Kupffer cells. Mol. Pharmacol. 59 4), 744-750.
41. Rusyn, I., Tsukamoto, H., and Thurman, R. G. (1998). WY-14,643 rapidly activates nuclear factor kappaB in Kupffer cells before hepatocytes. Carcinogenesis 19(7), 1217-1222.
42. Rusyn, I., Yamashina, S., Segal, B. H., Schoonhoven, R., Holland, S. M., Cattley, R. C., Swenberg, J. A., and Thurman, R. G. (2000). Oxidants from nicotinamide adenine dinucleotide phosphate oxidase are involved in triggering cell proliferation in the liver due to peroxisome proliferators. Cancer Res. 60(17), 4798-4803.
43. Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., and Klenk, D. C. (1985). Measurement of protein using bicinchoninic acid. Anal. Biochem. 150(1), 76-85.
44. Tomaszewski, K. E., Derks, M. C., and Melnick, R. L. (1987). Acyl CoA oxidase is the most suitable marker for hepatic peroxisomal changes caused by treatment of F344 rats with di(2-ethylhexyl)phthalate. Toxicol. Lett. 37(3), 203-212.
45. Tomaszewski, K. E., Heindel, S. W., Jenkins, W. L., and Melnick, R. L. (1990). Induction of peroxisomal acyl CoA oxidase activity and lipid peroxidation in primary rat hepatocyte cultures. Toxicology 65 1-2), 49-60.
46. Torrey, C. E., Campbell, J. A., Hoivik, D. J., Miller, R. T., Allen, J. S., Mann, P. C., Selinger, K., Rickert, D., Savina, P. M., and Santostefano, M. J. (2005). Evaluation of the carcinogenic potential of clofibrate in the p53+/- mouse. Int. J. Toxicol. 24(5), 289-299.
47. Varfolomeev, E. E., Schuchmann, M., Luria, V., Chiannilkulchai, N., Beckmann, J. S., Mett, I. L., Rebrikov, D., Brodianski, V. M., Kemper, O. C., Kollet, O., et al. (1998). Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/ Apo 1, and DR3 and is lethal prenatally. Immunity 9(2), 267-276.
48. Ward, J. M., Hagiwara, A., Anderson, L. M., Lindsey, K., and Diwan, B. A. (1988). The chronic hepatic or renal toxicity of di(2-ethylhexyl) phthalate, acetaminophen, sodium barbital, and phenobarbital in male B6C3F1 mice: Autoradiographic, immunohistochemical, and biochemical evidence for levels of DNA synthesis not associated with carcinogenesis or tumor promotion. Toxicol. Appl. Pharmacol. 96(3), 494-506.
49. Ward, J. M., Peters, J. M., Perella, C. M., and Gonzalez, F. J. (1998). Receptor and nonreceptor-mediated organ-specific toxicity of di(2-ethythexyl)phthalate (DEHP) in peroxisome proliferator-activated receptor alpha-null mice. Toxicol. Pathol. 26(2), 240-246.
50. Yeldandi, A. V, Milano, M., Subbarao, V., Reddy, J. K., and Rao, M. S. (1989). Evaluation of liver cell proliferation during ciprofibrate-induced hepatocarcinogenesis. Cancer Lett. 47, 21-27.
51. Yeldandi, A. V., Rao, M. S., and Reddy, J. K. (2000). Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis. Mutat. Res. 448(2), 159-177.